Champions Oncology Inc (CSBR) earnings · rev $59.4M
These earnings events as JSON? API free 100/dayChampions Oncology Inc (CSBR) is a biotechnology company listed on US.
This CSBR earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported CSBR revenue for 2026-04-30 was $59.4M. Net income was -$1.2M. Revenue was up 4.4% from 2025-04-30 to 2026-04-30. CSBR currently screens at market cap $99.8M.
When the next CSBR 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 4.4% from 2025-04-30 to 2026-04-30. An earnings headline that ignores that move is noise.
Not investment advice. Full CSBR research stays on the stock page; the tape stays on the quote page.
CSBR earnings FAQ
What are CSBR's latest revenue and net income?
Latest cached Champions Oncology Inc (CSBR) revenue for Apr 30, 2026 was $59.4M. Net income was -$1.2M. Statements: https://lician.com/financials/csbr
What is CSBR's latest diluted EPS?
Latest cached Champions Oncology Inc (CSBR) diluted EPS for Apr 30, 2026 was -$0.08.
What period does the latest CSBR earnings print cover?
The latest cached Champions Oncology Inc (CSBR) earnings print covers Apr 30, 2026. The prior cached period on this page is Apr 30, 2025.
How did CSBR revenue change from the prior cached period?
Cached Champions Oncology Inc (CSBR) revenue was up 4.4% from $56.9M (Apr 30, 2025) to $59.4M (Apr 30, 2026). Statements: https://lician.com/financials/csbr
Where are CSBR earnings listed?
Cached earnings facts for Champions Oncology Inc (CSBR) are listed at https://lician.com/earnings/csbr. Statements: https://lician.com/financials/csbr
Not investment advice.